A randomized controlled trial of the impact of protein supplementation on leg lean mass and integrated muscle protein synthesis during inactivity and energy restriction in older persons.
Study Goal
The researchers aimed to determine if collagen peptide supplementation could alleviate lean mass loss by enhancing muscle protein synthesis during inactivity and a hypoenergetic state.
Results Summary
Collagen peptide supplementation did not protect against leg lean mass loss during inactivity and energy restriction, nor did it enhance muscle protein synthesis during recovery, unlike whey protein.
Population
Older adults (16 men, mean age 69 ± 3 y; 15 women, mean age 68 ± 4 y)
Effective Dosage
30 g collagen peptides, consumed twice daily
Duration
5 weeks (1 week energy balance, 1 week energy restriction, 2 weeks energy restriction + step reduction, 1 week recovery)
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
protein supplementation | no change | leg lean mass | older persons | - | did not confer a benefit in protecting | #1 |
whey protein supplementation | increase | leg lean mass | older persons | - | augmented | #2 |
whey protein supplementation | increase | muscle protein synthesis | older persons | - | augmented | #3 |
diet containing 1.6 g protein · kg-1 · d-1 with whey protein or collagen peptides | decrease | leg lean mass | 16 men, mean ± SD age: 69 ± 3 y; 15 women, mean ± SD age: 68 ± 4 y | - | significant reductions in | #4 |
diet containing 1.6 g protein · kg-1 · d-1 with whey protein or collagen peptides | decrease | integrated muscle protein synthesis | 16 men, mean ± SD age: 69 ± 3 y; 15 women, mean ± SD age: 68 ± 4 y | - | decreased | #5 |
whey protein supplementation | increase | integrated muscle protein synthesis | 16 men, mean ± SD age: 69 ± 3 y; 15 women, mean ± SD age: 68 ± 4 y | - | increased | #6 |
BACKGROUND: In older persons, muscle loss is accelerated during physical inactivity and hypoenergetic states, both of which are features of hospitalization. Protein supplementation may represent a strategy to offset the loss of muscle during inactivity, and enhance recovery on resumption of activity. OBJECTIVE: We aimed to determine if protein supplementation, with proteins of substantially different quality, would alleviate the loss of lean mass by augmenting muscle protein synthesis (MPS) while inactive during a hypoenergetic state. DESIGN: Participants (16 men, mean ± SD age: 69 ± 3 y; 15 women, mean ± SD age: 68 ± 4 y) consumed a diet containing 1.6 g protein · kg-1 · d-1, with 55% ± 9% of protein from foods and 45% ± 9% from supplements, namely, whey protein (WP) or collagen peptides (CP): 30 g each, consumed 2 times/d. Participants were in energy balance (EB) for 1 wk, then began a period of energy restriction (ER; -500 kcal/d) for 1 wk, followed by ER with step reduction (ER + SR; <750 steps/d) for 2 wk, before a return to habitual activity in recovery (RC) for 1 wk. RESULTS: There were significant reductions in leg lean mass (LLM) from EB to ER, and from ER to ER + SR in both groups (P < 0.001) with no differences between WP and CP or when comparing the change from phase to phase. During RC, LLM increased from ER + SR, but in the WP group only. Rates of integrated muscle protein synthesis decreased during ER and ER + SR in both groups (P < 0.01), but increased during RC only in the WP group (P = 0.05). CONCLUSIONS: Protein supplementation did not confer a benefit in protecting LLM, but only supplemental WP augmented LLM and muscle protein synthesis during recovery from inactivity and a hypoenergetic state. This trial was registered at http://www.clinicaltrials.gov as NCT03285737.